Breaking News

BASi, Pinnacle Collaborate on Glucose Monitoring

May 2, 2013

Will combine methods for diabetes data collection

BASi has entered a collaboration with Pinnacle Technology for proof-of-concept studies combining BASi’s Culex NxT automated blood sampling system with Pinnacle’s glucose sensor to create a new option for quality data collection for diabetes and other glucose research.
 
“Our approach has two important advantages over traditional methods: automation of blood sampling made possible by our Culex NxT, and accurate monitoring of glucose levels using the Pinnacle glucose sensor with no net removal of blood from the test subjects. This allows researchers to take many glucose readings with no ill effects on the test subjects, resulting in more accurate glucose readings than are possible with manual sampling. The system also enables researchers to conduct pharmacokinetic, metabolism, telemetry or microdialysis studies from one set of test subjects instead of using three or four sets, thus lowering study costs,” said Jacqueline M. Lemke, president and chief executive officer and chief financial officer of BASi.

Related Compliance:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research